MPMaryna Postolaki

Maryna Postolaki

*This is an algorithmically generated author record based on publicly available information.

Maryna Postolaki has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long-term staged management of an extensive pelvic and right lower-extremity vascular malformation with major venous abnormalities and postprocedural pulmonary embolism: A case report

    by Artem Shchebetun, Olena Abramchuk, Alina Biletska, Yuliia Fomenko, Liliia Koshlak, Olena Chiernobaievska, Katsiaryna Miliuk, Anastasiia Plakhotniuk, Maryna Postolaki, Ingrida Zamoyska

  • Open Access

    THE GUT–BRAIN AXIS AND PSYCHOBIOTICS: IMPLICATIONS FOR MENTAL HEALTH – A NARRATIVE REVIEW

    by Alina Biletska, Olena Abramchuk, Yuliia Fomenko, Artem Shchebetun, Liliia Koshlak, Olena Chiernobaievska, Katsiaryna Miliuk, Anastasiia Plakhotniuk, Maryna Postolaki, Iia Zhaharina, et al.

    Background: The gut–brain axis has emerged as a key regulatory network linking intestinal microbiota with central nervous system activity. Increasing evidence suggests that gut dysbiosis contributes to the pathophysiology of depression and anxiety disorders through mechanisms involving neuroinflammation, hypothalamic–pituitary–adrenal (HPA) axis dysregulation, impaired intestinal barrier integrity, altered tryptophan metabolism, and abnormal microbial metabolite production. Aim: This review aimed to summarize the current evidence regarding the role of the gut–brain axis and psychobiotics in mental health, with particular emphasis on mechanistic pathways and recent clinical studies. Material and methods: A narrative review of the literature indexed in PubMed, Scopus, and Web of Science from 2019 to 2026 was conducted. Particular attention was given to randomized controlled trials, meta-analyses, mechanistic studies, and recent reviews on psychobiotics, gut microbiota, depression, anxiety, neuroinflammation, and precision psychiatry. Results: Current evidence indicates that selected psychobiotic strains, particularly Lactobacillus and Bifidobacterium species, may improve depressive and anxiety symptoms by modulating inflammatory cytokines, microglial activation, vagus nerve signaling, short-chain fatty acid synthesis, and serotonin precursor metabolism. Clinical studies have suggested modest but clinically relevant improvements in mood, cognitive function, stress response, and sleep quality following psychobiotic supplementation. Synbiotic therapy and Mediterranean dietary interventions may further enhance therapeutic outcomes. Conclusions: The gut–brain axis is a promising target in modern psychiatry. Although psychobiotics may constitute a valuable adjunctive strategy for treating depressive and anxiety disorders, further large-scale standardized clinical studies are necessary to establish strain-specific efficacy, optimal treatment duration, and clinically applicable biomarkers.

  • Open Access

    FROM FILTERED SKIN TO COSMETIC PROCEDURE REQUESTS: A NARRATIVE EVIDENCE REVIEW AND CLINICAL SCREENING FRAMEWORK FOR DERMATOLOGY AND AESTHETIC MEDICINE

    by Olena Abramchuk, Liliia Koshlak, Yaryna Manila, Lesia Slobozheniuk, Artem Shchebetun, Yuliia Fomenko, Alina Biletska, Olena Chiernobaievska, Katsiaryna Miliuk, Anastasiia Plakhotniuk, et al.

    Background. Image-centered social media have changed how patients observe, edit, compare, and evaluate their appearance [1, 2]. Beauty filters can erase acne, pores, pigment variation, erythema, scars, and lines while also altering facial proportions, creating a continuously available idealized version of the user’s own skin and face [3]. Dermatologists and aesthetic clinicians increasingly encounter procedure requests framed by filtered selfies, influencer content, and videoconferencing images [4, 15]. The popular expression “Snapchat dysmorphia” describes part of this phenomenon but is not a recognized diagnosis and should not be used interchangeably with body dysmorphic disorder (BDD) [1, 2, 37]. Aim. To synthesize evidence along the pathway from digital modification of skin and facial appearance to appearance anxiety and cosmetic procedure requests, and to develop an evidence-informed clinical screening framework for dermatology and aesthetic medicine. Methods. A structured narrative search of PubMed/Google Scholar was conducted through 4 October 2026 using combinations of terms related to social media, filters, selfies, photo editing, skin and facial appearance, appearance anxiety, BDD, cosmetic dermatology, cosmetic surgery, screening, and aesthetic procedures. Reference lists of relevant systematic reviews, meta-analyses, clinical reviews, and professional guidance were examined. Evidence was organized by its position in the proposed clinical pathway: digital exposure and self-editing, appearance comparison and anxiety, procedure consideration, dysmorphic symptoms, and consultation outcomes. Priority was given to systematic reviews and meta-analyses, experimental and longitudinal studies, validated screening research, and clinical guidance. Results. Systematic reviews and experiments indicate that exposure to idealized appearance content can worsen short-term body or facial satisfaction and increase appearance comparison. Active behaviors, including repeated selfie editing and filter use, show more consistent associations with cosmetic procedure acceptance than total social media time. The evidence supports a plausible but not fully established pathway from digital self-modification to self-discrepancy, appearance surveillance, anxiety, and procedure requests. Effect sizes vary, most studies involve young women, and evidence linking filter exposure to completed procedures or long-term psychiatric outcomes remains limited. BDD is substantially overrepresented in dermatology and cosmetic settings. The proposed framework combines assessment of the objective dermatologic finding, digital appearance behaviors, preoccupation and impairment, validated BDD screening, expectations, prior procedures, and mental health risk to guide treatment, extended assessment, deferral, or referral. Conclusions. Filtered skin and facial images should be treated as clinically relevant sources of comparison and procedure expectations rather than as diagnostic entities. The proposed framework translates heterogeneous evidence into a reproducible consultation process. A positive BDD screen does not establish a diagnosis, but probable BDD, an anatomically impossible target, marked functional impairment, acute psychological distress, or self-harm risk should lead to postponement of elective treatment and appropriate mental health assessment.